Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status:
Completed
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
This is a phase I/II prospective, randomized, multi-center, double-masked, vehicle-controlled
clinical trial evaluating the safety and efficacy of corneal collagen cross-linking the
keratoprosthesis carrier tissue in subjects who are candidates for high-risk keratoprosthesis
implantation but because of a history of corneal melts or autoimmune diseases are not
candidate for a traditional corneal transplant.